Drug · DIN 02459639
ZINBRYTA
PREFILLED PEN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since May 30, 2018.
- Drug Identification Number (DIN)
- 02459639
- Company (DIN owner)
- Biogen Canada IncToronto, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Daclizumab L04AC01
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DACLIZUMAB BETA | 150 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 8, 2016: NOC 18736New Drug Submission (NDS)
Other DINs named ZINBRYTA
- DIN 02459620 · Cancelled Post Market